Increased serum kallistatin levels in type 1 diabetes patients with vascular complications

Alicia J Jenkins, Jeffrey D McBride, Andrzej S Januszewski, Connie S Karschimkus, Bin Zhang, David N O'Neal, Craig L Nelson, Jasmine S Chung, C Alex Harper, Timothy J Lyons, Jian-Xing Ma

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Kallistatin, a serpin widely produced throughout the body, has vasodilatory, anti-angiogenic, anti-oxidant, and anti-inflammatory effects. Effects of diabetes and its vascular complications on serum kallistatin levels are unknown.
Original languageEnglish
Pages (from-to)19
JournalJournal of angiogenesis research
Volume2
DOIs
Publication statusPublished - 2010

Fingerprint Dive into the research topics of 'Increased serum kallistatin levels in type 1 diabetes patients with vascular complications'. Together they form a unique fingerprint.

  • Cite this

    Jenkins, A. J., McBride, J. D., Januszewski, A. S., Karschimkus, C. S., Zhang, B., O'Neal, D. N., Nelson, C. L., Chung, J. S., Harper, C. A., Lyons, T. J., & Ma, J-X. (2010). Increased serum kallistatin levels in type 1 diabetes patients with vascular complications. Journal of angiogenesis research, 2, 19. https://doi.org/10.1186/2040-2384-2-19